Mark Alwardt is Vice President, Medically Integrated Dispensing (MID), where he is responsible for McKesson’s advancement of the medically integrated community oncology model, including practice growth, expansion of the model, and deployment of innovative provider solutions (e.g. ScriptPASTM). In his role, Mark oversees McKesson MID operations, strategy, product delivery, and practice business development.
Prior to joining McKesson, Mark enjoyed 16 years at Humana leading a number of key organizations including the Provider Organized Delivery System, Humana Pharmacy Solutions Strategy & Business Development, Risk Adjustment & CMS Stars Business Development, and the Patient Health Outcomes Task Force.

He holds a bachelor’s degree from Excelsior College, is a Certified Professional in Healthcare Quality (CPHQ) through the National Association for Healthcare Quality, and a Certified Strength and Conditioning Specialist with Distinction (CSCS, *D) through the National Strength and Conditioning Association.